BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pancrazzi A, Magliocca P, Lorubbio M, Vaggelli G, Galano A, Mafucci M, Duranti D, Cortesi M, Mazzeschi E, Fabbroni S, Viti G, Tartaglia Polcini A, Tripodo E, Sanchini P, Gervino S, Tacconi D, Dei S, Mazzierli M, D'Urso A, Ognibene A. Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity. Clin Biochem 2020;84:87-92. [PMID: 32702365 DOI: 10.1016/j.clinbiochem.2020.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Renard N, Daniel S, Cayet N, Pecquet M, Raymond F, Pons S, Lupo J, Tourneur C, Pretis C, Gerez G, Blasco P, Combe M, Canova I, Lesénéchal M, Berthier F. Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays. J Clin Microbiol 2021;59:e02292-20. [PMID: 33419947 DOI: 10.1128/JCM.02292-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vaselli NM, Hungerford D, Shenton B, Khashkhusha A, Cunliffe NA, French N. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review. PLoS One 2021;16:e0250541. [PMID: 34727115 DOI: 10.1371/journal.pone.0250541] [Reference Citation Analysis]
3 Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ. A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19. Future Virol 2021. [PMID: 34950219 DOI: 10.2217/fvl-2021-0211] [Reference Citation Analysis]
4 De Munck DG, Peeters B, Huyghe E, Goossens H, Ieven M, Matheeussen V. Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection. Acta Clin Belg 2021;:1-6. [PMID: 34152943 DOI: 10.1080/17843286.2021.1940776] [Reference Citation Analysis]
5 Guerreiro M, Aguilar-Gallardo C, Montoro J, Francés-Gómez C, Latorre V, Luna I, Planelles D, Carrasco MP, Gómez MD, González-Barberá EM, Aguado C, Sempere A, Solves P, Gómez-Seguí I, Balaguer-Rosello A, Louro A, Perla A, Larrea L, Sanz J, Arbona C, de la Rubia J, Geller R, Sanz MÁ, Sanz G, Luis Piñana J. Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients? Transpl Infect Dis 2021;:e13602. [PMID: 33728702 DOI: 10.1111/tid.13602] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Sekirov I, Barakauskas VE, Simons J, Cook D, Bates B, Burns L, Masud S, Charles M, McLennan M, Mak A, Chahil N, Vijh R, Hayden A, Goldfarb D, Levett PN, Krajden M, Morshed M. SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia. J Clin Virol 2021;142:104914. [PMID: 34304088 DOI: 10.1016/j.jcv.2021.104914] [Reference Citation Analysis]